MRI-Volumetry in the Evaluation of Shunt Treatment for Hydrocephalus

Sponsor
Uppsala University (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04599153
Collaborator
(none)
30
1
2
37.7
0.8

Study Details

Study Description

Brief Summary

This randomized, double-blinded, cross-over study aim to evaluate the effects of shunt treatment in idiopathic normal pressure hydrocephalus (iNPH) by measuring cerebral ventricular volume and clinical symptoms at different shunt opening pressures. Further, proteins in the cerebrospinal fluid (CSF) will be compared before and after shunt surgery.

Condition or Disease Intervention/Treatment Phase
  • Other: Ventriculoperitoneal shunt opening pressure setting
N/A

Detailed Description

The participants are evaluated before surgery and one month, two months, three months and three months plus one day after surgery. At each evaluation point a MRI of the brain with volumetric sequences is performed and clinical data is collected (Walking speed and steps for Time up and go, 10m walking and 3m walking backwards. Mini Mental State Examination, balance, gait, self rating of incontinence, Epworth Sleepiness Scale).

At surgery, all patients are given a ventriculoperitoneal (VP) shunt (Strata ® ) with an opening pressure setting of 1.5. After the first evaluation, one month postoperatively, participants are randomized to either a higher (2.5) or a lower (1.0) opening pressure, ratio 1:1. The opening pressure setting is blinded both for patients and the clinician during the subsequent clinical evaluations. At two months, the opening pressure is crossed over to the alternative setting (2.5 or 1.0). At three months, all participants receive the lowest shunt opening pressure (0.5) with the final evaluation the next day.

Semiautomatic measurement of the lateral as well as the third cerebral ventricles will be performed using the MRI scans and volumetric software: SyMRI (SyntheticMR AB, Linköping, Sweden)

CSF is collected at three times for each participant, from the lumbar spine pre- and 3 months postoperatively and intracranially during surgery. Further, intracranial CSF is taken through the Rickham Reservoir at the 3 months postoperative evaluation. After CSF from the participants has been collected, a single batch mass spectrometry will be performed with all the samples simultaneously.

Sample size was determined to achieve 80% power for a two tailed paired t-test for a mean change in ventricular volume of 8ml, estimated from postoperative change in ventricular volume in a previous study.

Hypotheses:
  • The volume of the ventricular system in the brain decreases significantly after shunt-surgery.

  • The ventricular volume is larger at high opening pressures compared to low opening pressures of the shunt.

  • The decrease in ventricular volume is related to clinical outcome.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Randomized, double blinded crossover design.Randomized, double blinded crossover design.
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
Shunt setting at the two months and three months follow up.
Primary Purpose:
Treatment
Official Title:
MRI-Volumetry in the Evaluation of Shunt Treatment for Hydrocephalus, a Randomised, Double-blind Study.
Actual Study Start Date :
Oct 10, 2017
Anticipated Primary Completion Date :
Dec 1, 2020
Anticipated Study Completion Date :
Dec 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: High initial

At the one month follow-up, the shunt is adjusted into a high opening pressure (2.5), which is crossed over to 1.0 at the two months follow-up. At the three months follow-up the opening pressure is set at 0.5 until the next day.

Other: Ventriculoperitoneal shunt opening pressure setting
The ventriculoperitoneal shunt (Strata®) opening pressure can be changed using a magnetic tool. The possible settings are 0.5, 1.0, 1.5, 2.0, 2.5 with a higher setting number corresponding to a higher opening pressure and less drainage through the shunt. All settings are used in routine clinical practice.

Experimental: Low initial

At the one month follow-up, the shunt is adjusted into a low opening pressure (1.0), which is crossed over to 2.5 at the two months follow-up. At the three months follow-up the opening pressure is set at 0.5 until the next day.

Other: Ventriculoperitoneal shunt opening pressure setting
The ventriculoperitoneal shunt (Strata®) opening pressure can be changed using a magnetic tool. The possible settings are 0.5, 1.0, 1.5, 2.0, 2.5 with a higher setting number corresponding to a higher opening pressure and less drainage through the shunt. All settings are used in routine clinical practice.

Outcome Measures

Primary Outcome Measures

  1. Ventricular volume at different shunt settings (mL) [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in ventricular volume (ml) measured by MRI

  2. Time of "Timed Up and Go" test at different shunt settings [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in total walking time (sec) on "Timed Up and Go".

  3. Time of 10m walking test at different shunt settings [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in total walking time (sec) on 10m walking test.

Secondary Outcome Measures

  1. Ventricular versus lumbar cerebrospinal fluid composition determined by mass spectrometry [Cerebrospinal fluid is collected during diagnostic procedures before surgery, during surgery and three months and one day after surgery.]

    Change in CSF composition from ventricular versus lumbar collection sites. Quantified with mass spectrometry and statistically compared on a protein by protein basis.

  2. Change in CSF composition after surgery determined by mass spectrometry [Cerebrospinal fluid is collected during diagnostic procedures before surgery, during surgery and three months and one day after surgery.]

    Change in CSF composition before versus after surgery. Quantified with mass spectrometry and statistically compared on a protein by protein basis.

  3. Number of steps of "Timed Up and Go" test at different shunt settings [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in number of steps on "Timed Up and Go" test.

  4. Number of steps of "Timed Up and Go" test at different time points regardless of shunt setting [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in number of steps on "Timed Up and Go" test.

  5. Number of steps on 10m walking test at different shunt settings [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in number of steps on 10m walking test.

  6. Number of steps on 10m walking test at different time points regardless of shunt setting [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in number of steps on 10m walking test.

  7. Time of 3m backwards walking test at different shunt settings [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in total walking time (sec) on 3m backwards walking test.

  8. Time of 3m backwards walking test at different time points regardless of shunt setting [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in total walking time (sec) on 3m backwards walking test.

  9. Number of steps on 3m backwards walking test at different shunt settings [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in number of steps on 3m backwards walking test.

  10. Number of steps on 3m backwards walking test at different time points regardless of shunt setting [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in number of steps on 3m backwards walking test.

  11. Mini Mental State Examination at different shunt settings [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in MMSE results.

  12. Mini Mental State Examination at different time points regardless of shunt setting [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in MMSE results.

  13. Epworth sleepiness scale at different time points regardless of shunt setting [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in Epworth sleepiness scale rating.

  14. Epworth sleepiness scale at different shunt settings [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in Epworth sleepiness scale rating.

  15. Continence scale at different time points regardless of shunt setting [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in continence scale rating.

  16. Continence scale at different shunt settings. [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in continence scale rating.

  17. Balance scale at different shunt settings. [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in Balance scale rating.

  18. Balance scale at different time points regardless of shunt setting [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in Balance scale rating.

  19. Modified rankin scale at different time points regardless of shunt setting [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in Modified rankin scale rating.

  20. Modified rankin scale at different shunt settings. [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in Modified rankin scale rating.

  21. Gray matter volume at different time points regardless of shunt setting [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in whole brain grey matter volume measured by MRI (mL).

  22. Gray matter volume at different shunt settings. [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in whole brain grey matter volume measured by MRI (mL).

  23. White matter volume at different time points regardless of shunt setting [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in whole brain white matter volume measured by MRI (mL).

  24. White matter volume at different shunt settings. [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in whole brain white matter volume measured by MRI (mL).

  25. Time of "Timed Up and Go" test at different time points regardless of shunt setting [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in total walking time (sec) on "Timed Up and Go".

  26. Time of 10m walking test at different time points regardless of shunt setting [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in total walking time (sec) on 10m walking test.

  27. Ventricular volume at different time points regardless of shunt setting (mL) [Assessed before surgery and at one, two and, three months and three months plus one day post surgery.]

    Change in ventricular volume (mL) measured by MRI

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of idiopathic normal pressure hydrocephalus and planned treatment with shunt surgery.
Exclusion Criteria:
  • Ongoing anticoagulation treatment

  • Ongoing Clopidogrel treatment

  • Mini mental state examination results of 15 or lower.

  • Contraindications to magnetic resonance imaging.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Neurology Clinic, Östersund Hospital Östersund Jämtland Sweden 83183

Sponsors and Collaborators

  • Uppsala University

Investigators

  • Principal Investigator: Katarina Laurell, MD, PhD, Uppsala University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Katarina Laurell, Senior Lecturer/Associate Professor, Uppsala University
ClinicalTrials.gov Identifier:
NCT04599153
Other Study ID Numbers:
  • Dnr 2017-254-31M
First Posted:
Oct 22, 2020
Last Update Posted:
Oct 22, 2020
Last Verified:
Oct 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Katarina Laurell, Senior Lecturer/Associate Professor, Uppsala University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 22, 2020